Advertisement
YOU ARE HERE: LAT HomeCollectionsRhone Poulenc Company
IN THE NEWS

Rhone Poulenc Company

FEATURED ARTICLES
BUSINESS
December 8, 1999 | (Reuters)
The Federal Trade Commission said it conditionally approved the proposed merger of Germany's Hoechst and France's Rhone-Poulenc to create a huge new pharmaceutical firm, Aventis. The FTC voted 5 to 0 to support a proposed consent decree with Hoechst and Rhone-Poulenc, which will now be issued for public comment.
ARTICLES BY DATE
BUSINESS
December 8, 1999 | (Reuters)
The Federal Trade Commission said it conditionally approved the proposed merger of Germany's Hoechst and France's Rhone-Poulenc to create a huge new pharmaceutical firm, Aventis. The FTC voted 5 to 0 to support a proposed consent decree with Hoechst and Rhone-Poulenc, which will now be issued for public comment.
Advertisement
BUSINESS
May 21, 1999 | ERIC LICHTBLAU, TIMES STAFF WRITER
Two European giants in the vitamin industry agreed Thursday to plead guilty to criminal charges and pay a record $725 million in fines for conspiring to fix and inflate vitamin prices around the world in the 1990s. The scheme, said Justice Department officials, reached into virtually every American household through the artificial inflation of prices for over-the-counter dietary supplements and fortified products such as cereal and cattle nutrients.
BUSINESS
May 21, 1999 | ERIC LICHTBLAU, TIMES STAFF WRITER
Two European giants in the vitamin industry agreed Thursday to plead guilty to criminal charges and pay a record $725 million in fines for conspiring to fix and inflate vitamin prices around the world in the 1990s. The scheme, said Justice Department officials, reached into virtually every American household through the artificial inflation of prices for over-the-counter dietary supplements and fortified products such as cereal and cattle nutrients.
BUSINESS
November 26, 1998 | From Times Wire Services
Confirming weeks of speculation, German drug and chemical maker Hoechst said Wednesday that it is discussing a merger with Rhone-Poulenc of France, a union that would create the world's largest life sciences company. An announcement on the outcome is expected as early as next week, but Hoechst cautioned that "no guarantee can be made as to the outcome of the current discussions." The combined stock market value of the two companies would be about $46.
BUSINESS
February 3, 1994 | DAVID R. OLMOS, TIMES STAFF WRITER
Richard J. Trauger, chief scientist at Immune Response Corp., went to the international AIDS conference in Berlin last June to deliver what he thought was good news: promising results from clinical trials of the company's anti-AIDS therapy. Speaking with scientists and investors, he described how the Carlsbad, Calif., firm co-founded by Dr. Jonas Salk had achieved some success with a treatment that aims to boost the immune system of people infected with the HIV virus.
BUSINESS
November 26, 1998 | From Times Wire Services
Confirming weeks of speculation, German drug and chemical maker Hoechst said Wednesday that it is discussing a merger with Rhone-Poulenc of France, a union that would create the world's largest life sciences company. An announcement on the outcome is expected as early as next week, but Hoechst cautioned that "no guarantee can be made as to the outcome of the current discussions." The combined stock market value of the two companies would be about $46.
Los Angeles Times Articles
|